Ryan Ungaro

Dr. Ryan Ungaro is an Assistant Professor of Medicine in the Division of Gastroenterology at the Icahn School of Medicine at Mount Sinai. Dr. Ungaro received his undergraduate degree from Wesleyan University and his medical degree from the Icahn School of Medicine at Mount Sinai where he graduated Alpha Omega Alpha with Distinction in Research. He completed his internal medicine training and served as chief resident at the Mount Sinai Medical Center then went on to complete fellowship training in gastroenterology at the Mount Sinai Medical Center and served as chief gastroenterology fellow. Dr. Ungaro received training in translational inflammatory bowel disease (IBD) research as a Howard Hughes Medical Institute Research Fellow and completed a Masters in Biostatistics and Clinical Research Methods at Columbia University Mailman School of Public Health.

Dr. Ungaro specializes in the care of patients with ulcerative colitis and Crohn's disease. He is Director of the Comprehensive Care for the Recently Diagnosed IBD Patient (COMPASS-IBD) Program at the Mount Sinai IBD Clinical Center. This program provides interdisciplinary care for recently diagnosed inflammatory bowel disease (IBD) patients. His research focuses on understanding early IBD including the impact of early intervention on IBD outcomes and precision medicine approaches to improve risk stratification and optimization of therapy for recently diagnosed IBD patients. His work is supported by an NIH K23 Career Development Award. He is also co-founder of the SECURE-IBD Registry which aims to understand the impact of COVID-19 on IBD patients.

Dr. Ryan Ungaro is an Assistant Professor of Medicine in the Division of Gastroenterology at the Icahn School of Medicine at Mount Sinai. Dr. Ungaro received his undergraduate degree from Wesleyan University and his medical degree from the Icahn School of Medicine at Mount Sinai where he graduated Alpha Omega Alpha with Distinction in Research. He completed his internal medicine training and served as chief resident at the Mount Sinai Medical Center then went on to complete fellowship training in gastroenterology at the Mount Sinai Medical Center and served as chief gastroenterology fellow. Dr. Ungaro received training in translational inflammatory bowel disease (IBD) research as a Howard Hughes Medical Institute Research Fellow and completed a Masters in Biostatistics and Clinical Research Methods at Columbia University Mailman School of Public Health.

Dr. Ungaro specializes in the care of patients with ulcerative colitis and Crohn's disease. He is Director of the Comprehensive Care for the Recently Diagnosed IBD Patient (COMPASS-IBD) Program at the Mount Sinai IBD Clinical Center. This program provides interdisciplinary care for recently diagnosed inflammatory bowel disease (IBD) patients. His research focuses on understanding early IBD including the impact of early intervention on IBD outcomes and precision medicine approaches to improve risk stratification and optimization of therapy for recently diagnosed IBD patients. His work is supported by an NIH K23 Career Development Award. He is also co-founder of the SECURE-IBD Registry which aims to understand the impact of COVID-19 on IBD patients.

Lisa Malter, MD, FACG, is a Professor of Medicine at the NYU School of Medicine, the Director of Education for the NYU IBD Center and Director of the Inflammatory Bowel Disease Clinic at the Bellevue Hospital Center in New York City. Board-certified in Gastroenterology, Dr. Malter’s patient practice is focused primarily on inflammatory bowel disease, including Crohn’s disease and ulcerative colitis, and she has pioneered access to care for the underserved patient population at Bellevue. Dr. Malter’s academic interests include the study of inflammatory bowel disease, patient safety, and fellowship education. Dr. Malter teaches at the NYU Grossman School of Medicine and has published in Inflammatory Bowel Diseases,  The American Journal of Gastroenterology and CC360. She is a member of ACG, AGA, and the Crohn's and Colitis Foundation. She serves as the Editor of the ACG Universe, is a member of the ACG Training Committee, the ACG Education Task Force, and is a faculty advisor for the Crohn's &Colitis Foundation's Greater New York Fellows’ Education Committee. She created and created and directs IBD 101, a first year fellows course on IBD, in collaboration with NYU and the ACG.  Dr. Malter received her medical degree from Rosalind Franklin University/Chicago Medical School, completed her internal medicine internship and residency at The Mount Sinai Hospital in New York, and went on to complete a Gastroenterology fellowship at NYU Langone Medical Center.

David Choi completed his Doctor of Pharmacy degree at the University of Colorado School of Pharmacy. He went on to complete his PGY1 Pharmacy Residency and PGY2 Ambulatory residency at The Johns Hopkins Hospital. He is currently an Associate Director at University of Chicago Medicine Inflammatory Bowel Disease Center. He is very excited about advocating for increased pharmacists’ role in gastroenterology/hepatology as well as importance for patient advocacy in receiving the care they require. He feels passionately about treat to target to improve patient care and research related to improving patient outcomes.

Oriana M. Damas, MD, MSCTI, is an Associate Professor of Medicine at the University of Miami Miller School of Medicine. She also serves as the Director of Translational Studies for the Crohn’s and Colitis Center. Dr. Damas earned her medical degree from the University of Miami and completed her training in internal medicine and gastroenterology at the University of Miami and Jackson Memorial Hospital.

Her clinical practice and research focus on the care of patients with inflammatory bowel disease (IBD). Dr. Damas has conducted extensive research on environmental factors and the epidemiology of IBD. Her contributions to the field have earned her accolades, including the DREAM Award in recognition of her work with the Hispanic IBD community.

Dr. Damas has significant experience in running clinical trials, including innovative dietary trials, aimed at improving the quality of life for patients with IBD through lifestyle and dietary modifications. She is an NIH-funded researcher and currently serves as the principal investigator for a study developing an anti-inflammatory South Florida diet for IBD patients, which incorporates elements of traditional Latin foods from the region.

She has authored numerous original research articles, and she serves on the Editorial Boards of the prestigious Gastroenterology journal and Crohn’s & Colitis 360. In addition to her research, Dr. Damas is recognized as a national and international leader in her field. She is frequently invited to speak at national and international conferences and is an active member of the AGA n and the Crohn’s & Colitis Foundation.

Dr. Sara Horst MD, MPH, FACG, AGAF is a Professor in the division of Gastroenterology, Hepatology, & Nutrition at Vanderbilt University Medical Center. Dr. Horst completed her medical school and residency training at The Ohio State University and then went to Vanderbilt University Medical Center for Gastroenterology Fellowship and to obtain her Masters of Public Health. She joined the faculty at Vanderbilt University Medical Center in 2011. She is involved in clinical care of complex IBD care, complex amyloid care, clinical research, and teaching and mentoring medical students and housestaff. She is the medical director for VUMC Specialty Pharmacy, VUMC Telehealth director, and VUMC Associate Vice Chair of Clinical Affairs for Dept of Medicine. Her research interests involve enhancing EHR efficiencies in the care of IBD, telehealth in IBD, and medication adherence in IBD. She has extensively published in peer reviewed journals. She is also involved in clinical care improvement as an EPIC Physician Builder and is on the National EPIC GI Steering Board. She is an associate editor for American Journal of Gastroenterology.

Jami Kinnucan, MD, is an inflammatory bowel disease (IBD) specialist who joined the Mayo Clinic Florida practice in January 2021 as an Associate Professor of Medicine in the Division of Gastroenterology and Hepatology. She currently serves as the Clinical Practice Chair for the Division of Gastroenterology & Hepatology, Associate Chair for Digital Transformation and Practice Integration for the Department of Medicine and Medical Director for Plummer Chart Ambulatory Communication Solutions team. She is also the Director of the IBD Intestinal Ultrasound Program at Mayo Clinic Florida. She has been recognized as a fellow of the American College of Gastroenterology (ACG), American Gastroenterological Association (AGA), and Crohn's and Colitis Foundation. She is a former member of the ACG Board of Governors for the state of Michigan and the ACG Women in Gastroenterology Committee. She is active in the Crohn’s and Colitis Foundation and previous Co-Chair for the Women in IBD Task Force and prior member of the Government and Industry Affairs Committee for the National Scientific Advisory Committee. Dr. Kinnucan is the co-founder of the Michigan GI Society in 2020 and, most recently, co-founded the Florida Women in GI (2022) and Gastro Digital Health (2024) She serves as Associate Editor for the Crohn’s and Colitis 360 Journal. She is actively involved with research looking at the impact of cannabis in IBD and received a 2024 Mayo Clinic STARDOM award to evaluate the use of virtual reality on the impact of pain in patients with abdominal pain and Crohn’s disease.

Dr. Ryan Ungaro is an Assistant Professor of Medicine in the Division of Gastroenterology at the Icahn School of Medicine at Mount Sinai. Dr. Ungaro received his undergraduate degree from Wesleyan University and his medical degree from the Icahn School of Medicine at Mount Sinai where he graduated Alpha Omega Alpha with Distinction in Research. He completed his internal medicine training and served as chief resident at the Mount Sinai Medical Center then went on to complete fellowship training in gastroenterology at the Mount Sinai Medical Center and served as chief gastroenterology fellow. Dr. Ungaro received training in translational inflammatory bowel disease (IBD) research as a Howard Hughes Medical Institute Research Fellow and completed a Masters in Biostatistics and Clinical Research Methods at Columbia University Mailman School of Public Health.

Dr. Ungaro specializes in the care of patients with ulcerative colitis and Crohn's disease. He is Director of the Comprehensive Care for the Recently Diagnosed IBD Patient (COMPASS-IBD) Program at the Mount Sinai IBD Clinical Center. This program provides interdisciplinary care for recently diagnosed inflammatory bowel disease (IBD) patients. His research focuses on understanding early IBD including the impact of early intervention on IBD outcomes and precision medicine approaches to improve risk stratification and optimization of therapy for recently diagnosed IBD patients. His work is supported by an NIH K23 Career Development Award. He is also co-founder of the SECURE-IBD Registry which aims to understand the impact of COVID-19 on IBD patients.